Filed: 11/13/2025ACC: 0001999371-25-017685
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 93 equity positions with a total reported market value of $1.15B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
93
Positions
$1.15B
Total AUM (reported)
100.70M
Total Shares
Allocation by class
COM$537.35M46.8%
SPONSORED ADS$153.53M13.4%
COM NEW$95.07M8.3%
COM PAR $.01$94.33M8.2%
SHS$82.49M7.2%
TR UNIT$56.29M4.9%
COMMON STOCK$41.05M3.6%
Portfolio Concentration
Top 3$217.31M18.9%
4–10$297.93M26.0%
11–25$324.71M28.3%
Rest$308.03M26.8%
Top 3 weight
18.9%
Top 10 weight
44.9%
Voting Authority Distribution
Total shares with voting rights: 100.70M
Sole
Full voting authority
100.70M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole93
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings93
Rows:
INSMED INC
SOLEShares655K
TypeSH
Market value$94.33M
8.22%
Sole
655K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares625K
TypeSH
Market value$66.69M
5.81%
Sole
625K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares84.49K
TypeSH
Market value$56.29M
4.90%
Sole
84.49K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.40M
TypeSH
Market value$56.21M
4.90%
Sole
1.40M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares115K
TypeSH
Market value$52.75M
4.59%
Sole
115K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.17M
TypeSH
Market value$46.62M
4.06%
Sole
1.17M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares500K
TypeSH
Market value$41.05M
3.58%
Sole
500K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.25M
TypeSH
Market value$37.50M
3.27%
Sole
1.25M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares384.42K
TypeSH
Market value$33.24M
2.90%
Sole
384.42K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares360K
TypeSH
Market value$30.56M
2.66%
Sole
360K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$28.44M
2.48%
Sole
750K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.40M
TypeSH
Market value$28.28M
2.46%
Sole
1.40M
Shared
0.00
None
0.00
MERUS N V
SOLEShares285.77K
TypeSH
Market value$26.91M
2.34%
Sole
285.77K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares1.11M
TypeSH
Market value$26.85M
2.34%
Sole
1.11M
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares3.87M
TypeSH
Market value$25.70M
2.24%
Sole
3.87M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares2.80M
TypeSH
Market value$25.62M
2.23%
Sole
2.80M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares1.42M
TypeSH
Market value$23.79M
2.07%
Sole
1.42M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares500K
TypeSH
Market value$20.65M
1.80%
Sole
500K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares2.10M
TypeSH
Market value$19.74M
1.72%
Sole
2.10M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares350K
TypeSH
Market value$19.24M
1.68%
Sole
350K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares959.18K
TypeSH
Market value$18.45M
1.61%
Sole
959.18K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares300K
TypeSH
Market value$17.51M
1.53%
Sole
300K
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares2.10M
TypeSH
Market value$15.37M
1.34%
Sole
2.10M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares220.60K
TypeSH
Market value$14.65M
1.28%
Sole
220.60K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$13.52M
1.18%
Sole
200K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INSMED INCSOLE | COM PAR $.01 | 655K | SH | $94.33M 8.22% | 655K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 625K | SH | $66.69M 5.81% | 625K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 84.49K | SH | $56.29M 4.90% | 84.49K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.40M | SH | $56.21M 4.90% | 1.40M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 115K | SH | $52.75M 4.59% | 115K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.17M | SH | $46.62M 4.06% | 1.17M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 500K | SH | $41.05M 3.58% | 500K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 1.25M | SH | $37.50M 3.27% | 1.25M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 384.42K | SH | $33.24M 2.90% | 384.42K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 360K | SH | $30.56M 2.66% | 360K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 750K | SH | $28.44M 2.48% | 750K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.40M | SH | $28.28M 2.46% | 1.40M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 285.77K | SH | $26.91M 2.34% | 285.77K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 1.11M | SH | $26.85M 2.34% | 1.11M | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 3.87M | SH | $25.70M 2.24% | 3.87M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 2.80M | SH | $25.62M 2.23% | 2.80M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 1.42M | SH | $23.79M 2.07% | 1.42M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 500K | SH | $20.65M 1.80% | 500K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 2.10M | SH | $19.74M 1.72% | 2.10M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 350K | SH | $19.24M 1.68% | 350K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 959.18K | SH | $18.45M 1.61% | 959.18K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 300K | SH | $17.51M 1.53% | 300K | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 2.10M | SH | $15.37M 1.34% | 2.10M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 220.60K | SH | $14.65M 1.28% | 220.60K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 200K | SH | $13.52M 1.18% | 200K | 0.00 | 0.00 |
Page 1 of 4